[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100628113":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":28,"locations":23,"responsibleParty":37,"collaborators":40,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":51,"sex":52,"minAge":53,"maxAge":23,"enrollmentInfo":54,"targetDuration":23,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":65,"overallStatus":71,"whyStopped":23,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":23},{"fullName":5,"class":6},"University of Washington","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Neurodevelomental risk score","EXPERIMENTAL","Neurodevelopmental screening will likely use a new validated risk score. In the event that the risk score is not deemed accurate or acceptable, neurodevelopmental screening will use the the Global Scale for Early Development (GSED), Developmental Screen Questionnaire (DSQ), or another appropriate method identified by in-country experts.",[13],"Other: Neurodevelopmental screening",{"label":15,"type":10,"description":16,"interventionNames":17},"Neurodevelopmental screening method","Neurodevelopmental screening may use the Global Scale for Early Development (GSED), Developmental Screen Questionnaire (DSQ), or another appropriate method identified by in-country experts.",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"Neurodevelopmental screening","The two neurodevelopmental screening methods tested may include the Global Scale for Early Development (GSED), a new validated risk score, Developmental Screen Questionnaire (DSQ), or another appropriate method identified by in-country experts.",[9,15],null,[25],{"name":26,"affiliation":5,"role":27},"Anjuli D Wagner, PhD, MPH","PRINCIPAL_INVESTIGATOR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":23,"email":33},"Katy Sharrock, MS","CONTACT","8472350168","sharrock@uw.edu",{"name":26,"role":31,"phone":35,"phoneExt":23,"email":36},"978-460-2331","anjuliw@uw.edu",{"type":27,"investigatorFullName":38,"investigatorTitle":39,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"Anjuli Wagner","Associate Professor, Global Health",[41],{"name":42,"class":43},"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","NIH","100628113","implementation-outcomes-and-cost-effectiveness-of-developmental-monitoring-for-children-exposed-to-hiv-100628113",false,"NCT07457411","Implementation Outcomes and Cost-effectiveness of Developmental Monitoring for Children Exposed to HIV","IMPLEMENT","Inclusion Criteria:\n\n* Healthcare workers (HCW): age 18 years or older\n* HCW: working at one of the clinics engaged in the study caring for children at routine clinic appointments\n* Children: age 16-24 months\n* Children: attending routine clinic appointment at one of the clinics engaged in the study\n* Caregivers: age 18 years or older\n* Caregivers: caregiver of child eligible for participation\n\nExclusion Criteria:\n\n* None",true,"ALL","16 Months",{"count":55,"type":56},5000,"ESTIMATED","INTERVENTIONAL",[59],"NA","The goal of this study is to learn about how to best carry out neurodevelopmental screening methods (tests to see if a young child can use support with brain development) in routine clinic visits in Botswana and Kenya among children age 16-24 months old.\n\nThe main questions it aims to answer are: 1. when used in routine clinic visits by healthcare workers, how many children are able to get screened; 2. are the screening tools appropriate and how can they best be used; 3. how much time and money does it take to use the screening methods?\n\nThe investigators will compare two screening methods chosen by healthcare workers at the beginning of the study. Children will undergo a brief test of their brain development to see if they need further evaluation and support. Caregivers will be asked to complete a short survey to see what they thought of the screening test. Healthcare workers will complete brief surveys and interviews to see what they thought of carrying out the screening tests and how use of the screening tests can be improved in their clinics.",[62,63,64],"Neurodevelpmental Delays","Neurodevelopment","Neurodevelopment Outcome",[66,67,68,20,69,70],"Implementation science","Neurodevelpment","Neurodevelopmental delays","Neurodevelopmental outcome","High HIV prevalence settings","NOT_YET_RECRUITING","2026-03-02",{"date":74,"type":75},"2026-03-09","ACTUAL",{"date":77,"type":56},"2027-01",{"date":79,"type":56},"2028-03",{"name":5,"class":6}]